Literature DB >> 14769830

Nontraditional risk factors for cardiovascular disease in diabetes.

V Fonseca1, C Desouza, S Asnani, I Jialal.   

Abstract

People with type 2 diabetes are disproportionately affected by cardiovascular disease (CVD), compared with those without diabetes. Traditional risk factors do not fully explain this excess risk, and other "nontraditional" risk factors may be important. This review will highlight the importance of nontraditional risk factors for CVD in the setting of type 2 diabetes and discuss their role in the pathogenesis of the excess CVD morbidity and mortality in these patients. We will also discuss the impact of various therapies used in patients with diabetes on nontraditional risk factors.

Entities:  

Mesh：

Year:  2004        PMID： 14769830     DOI： 10.1210/er.2002-0034

Source DB:  PubMed          Journal:  Endocr Rev        ISSN： 0163-769X            Impact factor:   19.871


  34 in total

1.  Is Acupuncture Effective for Improving Insulin Resistance? A Systematic Review and Meta-analysis.

Authors:  Ai-Qun Song; Yang-Pu Zhang; Rui Chen; Feng-Xia Liang
Journal:  Curr Med Sci       Date:  2018-12-07

2.  Ameliorative potential of conditioning on ischemia-reperfusion injury in diabetes.

Authors:  Ashish K Rehni; Kunjan R Dave
Journal:  Cond Med       Date:  2018-04-20

3.  Relationships between serum levels of thyroid hormones and serum concentrations of asymmetric dimethylarginine (ADMA) and N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patients with Graves' disease.

Authors:  Li-Qun Gu; Lin Zhao; Wei Zhu; Feng-Ying Li; Min-Jia Zhang; Yun Liu; Jian-Min Liu; Guang Ning; Yong-Ju Zhao
Journal:  Endocrine       Date:  2011-03-09       Impact factor: 3.633

4.  Central venous catheter-related thrombosis in senile male patients: New risk factors and predictors.

Authors:  Gao Liu; Zhi-Qing Fu; Ping Zhu; Shi-Jun Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

5.  Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials.

Authors:  V Fonseca; A Seftel; J Denne; P Fredlund
Journal:  Diabetologia       Date:  2004-11-25       Impact factor: 10.122

6.  Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease.

Authors:  Tina K Thethi; Muhammad A Bajwa; Husam Ghanim; Chanhee Jo; Monica Weir; Allison B Goldfine; Guillermo Umpierrez; Cyrus Desouza; Paresh Dandona; Ying Fang-Hollingsworth; Vasudevan Raghavan; Vivian A Fonseca
Journal:  J Diabetes Complications       Date:  2015-01-13       Impact factor: 2.852

Review 7.  Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?

Authors:  Iciar Martín-Timón; Cristina Sevillano-Collantes; Amparo Segura-Galindo; Francisco Javier Del Cañizo-Gómez
Journal:  World J Diabetes       Date:  2014-08-15

8.  Bromelain and cardiovascular risk factors in diabetes: An exploratory randomized, placebo controlled, double blind clinical trial.

Authors:  Chit Moy Ley; Qing Ni; Xing Liao; Huai-Lin Gao; Nicola Robinson
Journal:  Chin J Integr Med       Date:  2016-07-13       Impact factor: 1.978

9.  Role of metabolic environment on nitric oxide mediated inhibition of neointimal hyperplasia in type 1 and type 2 diabetes.

Authors:  Monica P Rodriguez; Zachary M Emond; Zheng Wang; Janet Martinez; Qun Jiang; Melina R Kibbe
Journal:  Nitric Oxide       Date:  2013-12-12       Impact factor: 4.427

10.  Diabetic atherosclerosis in APOE*4 mice: synergy between lipoprotein metabolism and vascular inflammation.

Authors:  Lance A Johnson; Hyung-Suk Kim; Melissa J Knudson; C Taylor Nipp; Xianwen Yi; Nobuyo Maeda
Journal:  J Lipid Res       Date:  2012-11-30       Impact factor: 5.922
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.